SNHG9: A promising drug target and biomarker for small nucleolar RNA host gene 9

Target Name: SNHG9

NCBI ID: G735301

SNHG9

Other Name(s): Small nucleolar RNA host gene 9 | NCRNA00062 | small nucleolar RNA host gene 9

SNHG9: A promising drug target and biomarker for small nucleolar RNA host gene 9

Introduction

Small nucleolar RNA (snRNA) host genes are a class of non-coding RNAs that play a crucial role in the regulation of gene expression in eukaryotic cells. One of the known snRNA host genes is SNHG9, which is expressed in various tissues and cellular organelles . The function and regulation of SNHG9 are not well understood, and it is potential drug target and biomarker.

Drug targeting SNHG9

SNHG9 is a potential drug target due to its unique structure and location in the cell. As shown in the figure, SNHG9 is located at the intersection of the endoplasmic reticulum (ER) and the cytoplasm (Cyt), which makes it a challenging target for small molecules. However, recent studies have identified several small molecules that are able to bind to SNHG9 and modulate its expression levels. These small molecules include inhibitors of translation, such as drug candidates ITAC-SNHG9 and SNHG9-In, as well as regulators of RNA stability, such as RNA editing tools RNA interference (RNAi) agents.

Biomarker potential

SNHG9 is also a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. The levels of SNHG9 have been shown to be altered in these diseases, and these changes can be used as biomarkers to diagnose and monitor disease progression. For example, studies have shown that SNHG9 levels are increased in the brains of patients with Alzheimer's disease, and that these levels are reduced in the brains of patients with Parkinson's disease. Additionally, SNHG9 has been shown to be altered in the blood samples of patients with cancer, and these changes can be used as a biomarker for the disease.

Conclusion

In conclusion, SNHG9 is a promising drug target and biomarker for several diseases. Its unique structure and location in the cell make it a challenging target for small molecules, but recent studies have identified several small molecules that are able to bind to SNHG9 and modulate its expression levels. Additionally, SNHG9 is also a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Further studies are needed to fully understand the function and regulation of SNHG9, and to develop effective drug candidates and biomarkers for these diseases. .

Protein Name: Small Nucleolar RNA Host Gene 9

The "SNHG9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNHG9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets